Factor XI and XII as antithrombotic targets

Arterial and venous thrombosis are major causes of morbidity and mortality, and the incidence of thromboembolic diseases increases as a population ages. Thrombi are formed by activated platelets and fibrin. The latter is a product of the plasma coagulation system. Currently available anticoagulants...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Current opinion in hematology Ročník 18; číslo 5; s. 349
Hlavní autoři:	Müller, Felicitas, Gailani, David, Renné, Thomas
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	United States 01.09.2011
Témata:	Animals Anticoagulants - pharmacology Anticoagulants - therapeutic use Blood Coagulation - drug effects Blood Coagulation - physiology Factor XI - antagonists & inhibitors Factor XI - metabolism Factor XI Deficiency - blood Factor XI Deficiency - drug therapy Factor XI Deficiency - metabolism Factor XII - antagonists & inhibitors Factor XII - metabolism Factor XII Deficiency - blood Factor XII Deficiency - drug therapy Factor XII Deficiency - metabolism Hemostasis - drug effects Hemostasis - physiology Humans Thrombosis - drug therapy Thrombosis - metabolism
ISSN:	1531-7048, 1531-7048
On-line přístup:	Zjistit podrobnosti o přístupu
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!